wada prohibited list 2025 s0 unapproved substances bpc-157 The World Anti-Doping Agency (WADA) has published the 2026 of and Methods on 1 October 2025. It is important that athletes and athlete support team members are WADA's 2026 Prohibited List now
Description
Musculoskeletal Injuries Tendon, ligament, and muscle injuries Achilles tendon, rotator cuff, MCL/ACL damage, muscle strains, and various tendinopathies
Two HGF protease inhibitors have been identified, HGF activator inhibitor (HAI)-1 and/or HAI-2, which control the activation of HGF ligand to limit the production of active HGF (Kaido et al., 2004
Typical daily range: 250 mcg per injection, 2 daily for those referencing twice-daily BPC-157 schedules
PRODUODOPA (foslevodopa/foscarbidopa) was developed by AbbVie as an innovative solution for advanced Parkinsons disease, particularly for patients who suffer from severe motor fluctuations and for whom traditional treatments were no longer effective
Its not a medication, and its not approved for human or animal use outside of authorized studies Cagrilintide is a synthetic, long-acting analog of amylin supplied for in-vitro research into peptide-mediated signaling pathways related to satiety, gastric function, and metabolic regulation
May be repurchased every 30 days
